Suppr超能文献

糖皮质激素的生物调节剂:糖皮质激素作用的增强剂和抑制剂

Biomodulators of glucocorticoid: amplifiers and suppressors of glucocorticoid action.

作者信息

Kido H, Katunuma N

机构信息

Institute for Enzyme Research, University of Tokushima, Japan.

出版信息

J Nutr Sci Vitaminol (Tokyo). 1992;Spec No:279-82. doi: 10.3177/jnsv.38.special_279.

Abstract

We have found several compounds that specifically modulate the action of glucocorticoid in vivo and in vitro without themselves having any glucocorticoid-like action and have proposed the concept of "Glucocorticoid Action Biomodulators". These biomodulators consist of "Glucocorticoid Sensitivity Amplifier" (GSA), "Glucocorticoid Potency Amplifiers" (GPAs), and suppressors of glucocorticoid action. GSA increased the incorporation of glucocorticoid into the liver and its binding to cytosol receptor without changing the total receptor concentration in liver cytosol and the equilibrium constant of the glucocorticoid binding reaction. GPAs, potent activators of protein kinase C, markedly enhanced the glucocorticoid action and the glucocorticoid action was inhibited by the inhibitors of protein kinase C. H-7, an inhibitor of protein kinase C, inhibited the translocation of glucocorticoid-receptor complex into nuclei without affecting the extent of phosphorylation of glucocorticoid receptor. These findings suggest that GPA(s) and the suppressors modulate some protein(s) which regulates the translocation of glucocorticoid receptor into nuclei.

摘要

我们已经发现了几种化合物,它们在体内和体外能特异性调节糖皮质激素的作用,而自身并无任何糖皮质激素样作用,我们提出了“糖皮质激素作用生物调节剂”的概念。这些生物调节剂包括“糖皮质激素敏感性增强剂”(GSA)、“糖皮质激素效能增强剂”(GPA)以及糖皮质激素作用抑制剂。GSA增加了糖皮质激素在肝脏中的掺入及其与胞浆受体的结合,而不改变肝脏胞浆中总受体浓度以及糖皮质激素结合反应的平衡常数。GPA是蛋白激酶C的强效激活剂,能显著增强糖皮质激素的作用,且糖皮质激素的作用被蛋白激酶C抑制剂所抑制。蛋白激酶C抑制剂H-7抑制糖皮质激素-受体复合物向细胞核的转位,而不影响糖皮质激素受体的磷酸化程度。这些发现提示,GPA和抑制剂调节了某些调控糖皮质激素受体向细胞核转位的蛋白质。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验